Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763795
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 DiabetesSuperior UniversityActive Not RecruitingNot Applicable
NCT07763795Active Not Recruiting
Not Applicable
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and Q...Superior University
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07762820
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder TumorsLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07762820Not Yet Recruiting
Not Applicable
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retr...Ludwig-Maximilians - Univ...
NCT07763522
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced ParesisHelsinki University Central HospitalEnrolling By InvitationNot Applicable
NCT07763522Enrolling By Invitation
Not Applicable
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Asses...Helsinki University Centr...
NCT07762157
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute ExacerbationNorth District HospitalRecruitingNot Applicable
NCT07762157Recruiting
Not Applicable
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chroni...North District Hospital
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762638
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302Idorsia Pharmaceuticals Ltd.Unknown
NCT07762638Unknown
—
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated...Idorsia Pharmaceuticals L...
NCT07762469
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin XuNot Yet Recruiting
NCT07762469Not Yet Recruiting
—
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin Xu
NCT07763899
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763899Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07764068
Targeted Deep Pelvic Floor Muscle Physiotherapy Versus Antenatal Perineal Massage in Nulliparous WomenMeir Medical CenterCompletedNot Applicable
NCT07764068Completed
Not Applicable
Targeted Deep Pelvic Floor Muscle Physiotherapy Versus Antenatal Perineal Massag...Meir Medical Center
NCT07762430
Food Noise Survey Development and Validation in Hindi and English-Speaking AdultsDiabetes Foundation, IndiaNot Yet Recruiting
NCT07762430Not Yet Recruiting
—
Food Noise Survey Development and Validation in Hindi and English-Speaking Adult...Diabetes Foundation, Indi...
NCT07762963
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa UniversityNot Yet Recruiting
NCT07762963Not Yet Recruiting
—
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa Unive...
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07762729
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up StudyChildren's Hospital of Fudan UniversityEnrolling By Invitation
NCT07762729Enrolling By Invitation
—
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up...Children's Hospital of Fu...
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07764354
How Patient Education Helps Patients With Chronic Musculoskeletal Disorders Stick to Home Exercise for Pain Relief.Imam Abdulrahman Bin Faisal UniversityRecruitingNot Applicable
NCT07764354Recruiting
Not Applicable
How Patient Education Helps Patients With Chronic Musculoskeletal Disorders Stic...Imam Abdulrahman Bin Fais...
NCT07764133
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian CancerUniversity of Tennessee Graduate School of MedicineRecruiting
NCT07764133Recruiting
—
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation a...University of Tennessee G...
Result Breakdown
Not yet recruiting7 (35%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting2 (10%)
Enrolling by invitation2 (10%)
Unknown1 (5%)
not_applicable11 (55%)
Not Specified6 (30%)
Phase 21 (5%)
Phase 11 (5%)
Phase 31 (5%)